NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 870 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $170,000 | +11.8% | 1,775 | 0.0% | 0.09% | -2.1% |
| Q4 2018 | $152,000 | 0.0% | 1,775 | 0.0% | 0.10% | +26.3% |
| Q3 2018 | $152,000 | +3.4% | 1,775 | -2.7% | 0.08% | -10.6% |
| Q1 2018 | $147,000 | -3.9% | 1,825 | 0.0% | 0.08% | -2.3% |
| Q4 2017 | $153,000 | -1.9% | 1,825 | 0.0% | 0.09% | -6.5% |
| Q3 2017 | $156,000 | +1.3% | 1,825 | -1.4% | 0.09% | -5.1% |
| Q2 2017 | $154,000 | -99.9% | 1,850 | -1.3% | 0.10% | +14.0% |
| Q1 2017 | $139,256,000 | +6.2% | 1,875 | +4.2% | 0.09% | +1.2% |
| Q4 2016 | $131,112,000 | -45.1% | 1,800 | -40.5% | 0.08% | -47.2% |
| Q3 2016 | $238,854,000 | -13.6% | 3,025 | -9.7% | 0.16% | -10.6% |
| Q2 2016 | $276,408,000 | +33.9% | 3,350 | +17.5% | 0.18% | +18.4% |
| Q1 2016 | $206,454,000 | +77514.3% | 2,850 | -8.1% | 0.15% | -13.6% |
| Q4 2015 | $266,000 | – | 3,100 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |